Joseph H. Capper - 09 Jun 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Jun 2026, 18:10:55 UTC
Prior SEC filing
06 Mar 2026
Next SEC filing
23 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan Smeykal, Attorney-in-Fact

Key filing fact

Joseph H. Capper filed Form 4 for TELA Bio, Inc. (TELA) on 11 Jun 2026.

Key facts

  • This page summarizes Joseph H. Capper's Form 4 filing for TELA Bio, Inc. (TELA).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2026, 18:10.

Change

  • Previous filing in this sequence was filed on 06 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001456817 Primary reporting owner

Capper Joseph H

Relationship
Director
Address
C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Signature date
11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Award

Transaction value
Shares
+11,925
Change %
Price
$0.000000*
Shares after
11,925
Date
09 Jun 2026
Ownership
Direct
Footnotes
F1
TELA transaction

Common Stock

Award

Transaction value
Shares
+11,675
Change %
+98%
Price
$0.000000*
Shares after
23,600
Date
09 Jun 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+17,550
Change %
Price
$0.000000*
Shares after
17,550
Date
09 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,550
Exercise price
$0.9350
Footnotes
F3
TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+17,335
Change %
Price
$0.000000*
Shares after
17,335
Date
09 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,335
Exercise price
$0.9350
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F2

These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F3

The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F4

The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .